let’s analyse why DEP- Gemcitibine may not happened after years...

let’s analyse why DEP- Gemcitibine may not happened after years :

1. problems in development - not work so good or too toxic
2 problems In Manufacture- can’t make it well
3. Problem in regulatory- can’t get approval to run study.
4. problems in commercial- no sufficient market for product
5. Problems in IP - no patent for a another similar DEP product or someone else has blocking patent.
6. Problem generally with SPL management incompetence.

some of these can be overcome but some not.

Now the list of excuses Jacky may give:
1 covid
2 covid
3 covid
4 late stage discussions with partner in Russia
5. Too busy doing viraleze deals in india
6. Very Busy arguing with regulators .
7. too busy with board appointments and getting botox
8. Other scapegoat is to blame- regulator, advisor or ex employee. Maybe her dog ate the 10000 page document. Poor poor little puppy.
9. Prefer to spend $m on her salary instead. Maybe can drag this cushy job out another 15years before old Rob Thomas notice not achieving much.
10. look at the new sparkly flashing glowy thing over there. Don’t worry retail shareholders, I do this all for you.